Rhumbline Advisers raised its position in HCA Healthcare Inc (NYSE:HCA) by 2.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 441,565 shares of the company’s stock after acquiring an additional 9,754 shares during the period. Rhumbline Advisers’ holdings in HCA Healthcare were worth $38,787,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently bought and sold shares of HCA. Dynamic Technology Lab Private Ltd bought a new position in HCA Healthcare in the second quarter valued at about $444,000. Mutual of America Capital Management LLC lifted its holdings in HCA Healthcare by 2.2% in the third quarter. Mutual of America Capital Management LLC now owns 35,732 shares of the company’s stock valued at $2,844,000 after acquiring an additional 761 shares during the period. APG Asset Management N.V. lifted its holdings in HCA Healthcare by 141.4% in the third quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock valued at $272,467,000 after acquiring an additional 2,005,193 shares during the period. Strs Ohio increased its position in HCA Healthcare by 12.2% in the third quarter. Strs Ohio now owns 1,075,778 shares of the company’s stock worth $85,621,000 after buying an additional 117,000 shares in the last quarter. Finally, Nationwide Fund Advisors increased its position in HCA Healthcare by 7.7% in the third quarter. Nationwide Fund Advisors now owns 423,184 shares of the company’s stock worth $33,681,000 after buying an additional 30,220 shares in the last quarter. 74.14% of the stock is currently owned by institutional investors.
In related news, SVP Sandra L. Morgan sold 3,698 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $96.91, for a total transaction of $358,373.18. Following the completion of the sale, the senior vice president now directly owns 5,410 shares of the company’s stock, valued at approximately $524,283.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Bill B. Rutherford sold 48,462 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $102.42, for a total value of $4,963,478.04. Following the sale, the chief financial officer now directly owns 41,269 shares of the company’s stock, valued at $4,226,770.98. The disclosure for this sale can be found here. Insiders have sold a total of 396,106 shares of company stock valued at $39,582,273 over the last three months. 2.90% of the stock is owned by corporate insiders.
HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, January 30th. The company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.25. The business had revenue of $11.56 billion during the quarter, compared to analyst estimates of $11.19 billion. HCA Healthcare had a negative return on equity of 49.49% and a net margin of 4.89%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the company earned $1.80 EPS. sell-side analysts predict that HCA Healthcare Inc will post 8.71 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Investors of record on Thursday, March 1st will be paid a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend is Wednesday, February 28th.
A number of analysts have commented on the company. Piper Jaffray Companies restated a “hold” rating and issued a $101.00 price target on shares of HCA Healthcare in a research report on Tuesday, January 30th. Sanford C. Bernstein restated a “market perform” rating and issued a $116.00 price target (up previously from $105.00) on shares of HCA Healthcare in a research report on Thursday, February 1st. BMO Capital Markets increased their target price on HCA Healthcare from $96.00 to $115.00 and gave the stock an “outperform” rating in a research report on Thursday, February 1st. They noted that the move was a valuation call. Argus increased their target price on HCA Healthcare from $9.26 to $114.00 and gave the stock a “buy” rating in a research report on Monday, February 12th. Finally, Leerink Swann increased their target price on HCA Healthcare from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $104.50.
TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at https://www.chaffeybreeze.com/2018/02/20/rhumbline-advisers-purchases-9754-shares-of-hca-healthcare-inc-hca.html.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.